Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pike

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
Neuromuscular Disorders : NMD|March 29, 2011
Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathiesStephanie A Robb, Caroline A Sewry, James J Dowling, et al.
Science Signaling|September 15, 2016
Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AMLIsabel Morgado-Palacin, Amanda Day, Matilde Murga, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2021
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferaseDaniel H O' Donovan, Clare Gregson, Martin J Packer, et al.
Journal of Medicinal Chemistry|February 3, 2015
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2Kurt G Pike, Jeff Morris, Linette Ruston, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2009
Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTORKeith A Menear, Sylvie Gomez, Karine Malagu, et al.
Molecular Cancer Therapeutics|September 12, 2015
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous SchedulesSylvie M Guichard, Jon Curwen, Teeru Bihani, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM InhibitorsBernard Barlaam, Elaine Cadogan, Andrew Campbell, et al.
Cancer|June 29, 2019
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national databaseAmandeep R Mahal, Santino Butler, Idalid Franco, et al.
Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.
Nature Communications|August 17, 2023
Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasisAnna Skakodub, Henry Walch, Kathryn R Tringale, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Neuromuscular Disorders : NMD|March 29, 2011
Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathiesStephanie A Robb, Caroline A Sewry, James J Dowling, et al.
Science Signaling|September 15, 2016
Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AMLIsabel Morgado-Palacin, Amanda Day, Matilde Murga, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2021
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferaseDaniel H O' Donovan, Clare Gregson, Martin J Packer, et al.
Journal of Medicinal Chemistry|February 3, 2015
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2Kurt G Pike, Jeff Morris, Linette Ruston, et al.
Bioorganic & Medicinal Chemistry Letters|September 8, 2009
Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTORKeith A Menear, Sylvie Gomez, Karine Malagu, et al.
Molecular Cancer Therapeutics|September 12, 2015
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous SchedulesSylvie M Guichard, Jon Curwen, Teeru Bihani, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM InhibitorsBernard Barlaam, Elaine Cadogan, Andrew Campbell, et al.
Cancer|June 29, 2019
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national databaseAmandeep R Mahal, Santino Butler, Idalid Franco, et al.
Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.
Nature Communications|August 17, 2023
Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasisAnna Skakodub, Henry Walch, Kathryn R Tringale, et al.
Pageof 20